April 9, 2015 – Children with common allergic diseases such as atopic dermatitis and allergic rhinitis showed a greater risk for developing primary immune thrombocytopenia, according to study results.
March 31, 2015 – A ninth-century remedy for eye infections has been found to kill the modern-day superbug MRSA and disrupt naturally antibiotic-resistant biofilms in tests conducted by researchers.
March 10, 2015 – On March 9, 2015, NEA CEO Julie Block, 13-year old eczema patient Isaiah, 17-year old eczema patient Gracie, and their parents were present at an important Food and Drug Administrative (FDA) hearing regarding the unmet medical need for atopic dermatitis therapies in pediatrics.
March 10, 2015 – Step toward a cure for eczema with us – be an eczema advocate and advance research!
March 5, 2015 – Check out this NPR piece on an important new study about how eczema affects the lives of people who have it by NEA Scientific Advisory Committee member Jonathan Silverberg, MD. Data from this study demonstrates the burden of living with eczema, which helps further the case for more eczema research.
March 4, 2015 – Children born to mothers who were exposed to secondhand tobacco smoke during pregnancy face an elevated risk of eczema and other skin problems in childhood.
February 25, 2015 – The study showed that those whose parents said they mostly wash the family’s dishes by hand were significantly less likely to develop eczema, and somewhat less likely to develop allergic asthma and hay fever.
February 24, 2015 – To critically review the body of clinical trials that refute or support the efficacy of antihistamines in relieving pruritus in patients with atopic dermatitis.
February 24, 2015 – The incidence of contact dermatitis in healthcare workers, combined with an increase of healthcare infections, warrants stronger efforts to identify products.
February 24, 2015 – Introduction of peanut products into the diets of infants at high risk of developing peanut allergy was safe and led to an 81 percent reduction in the subsequent development of the allergy, a clinical trial has found.